Skip to main content

Menu

Close

Close

Search

Back Our research
- Back Our research strategy We are connecting scientists and clinicians, working together to tackle three key research challenges.
  - Back Browse research projects
- Back Target discovery We are identifying, prioritising and validating therapeutic nucleic acids that will leverage endogenous reparative processes to generate new heart muscle, promote vessel formation and resolve fibrosis.
- Back Cardiac delivery We are developing cardiac-specific targeting mechanisms to administer therapeutic nucleic acids to the heart using innovative nanoformulations and viral vectors.
- Back Clinical translation We are building a pipeline to test and evaluate new medicines based on therapeutic nucleic acids and readying ourselves for a structured approach to clinical trials.
- Back Browse research projects
Back Our approach
- Back Our approach to research We are building a community and environment that fosters open, collaborative and equitable research practice.
- Back Culture and inclusion
- Back Patient partnerships
- Back Responsible research
Back Our people
- Back Our people profiles Browse profiles of our research teams and partners working across the UK and beyond.
- Back Leadership team
- Back Operations team
- Back Browse all our people
Back Knowledge hub
- Back Knowledge hub listings Explore our growing library of resources and outputs, with contributions from our teams and trusted partners.
- Back Academic publications Links to open access journal articles from our research teams.
Back Opportunities
- Back Opportunities to explore Discover what our centre offers staff, students, collaborators and partners, and how you can get involved.
  - Back Funding
  - Back Training
- Back Jobs View current vacancies with REACT across our partner organisations and find out how to apply.
- Back Studentships Find out more about PhD projects available with REACT in Edinburgh, London and Oxford.
- Back Events Discover our events, where REACT members and collaborators come together in person and online.
- Back Apply now: new pump-prime funding for early career researchers We are awarding £5-20k consumables funding for innovative projects developing therapies for cardiac repair and regeneration to ECRs based at King's, Edinburgh or Oxford.
- Back Funding
- Back Training
Back News
- Back News feed Read, watch and listen to updates, announcements and media appearances from our team.
  - Back Sign up to our newsletter
- Back Read: Paul Riley elected as Fellow of the Royal Society 27 May 2026
- Back Read: Independent Strategic Advisory Board meets 20 April 2026
- Back Read: first symposium brings REACT together 25 March 2026
- Back Sign up to our newsletter

Close

Search

Breadcrumb

Home
Our people
Dr Peter Vegh

Dr Peter Vegh

Biofoundry Computational Biology Lead

Person icon on gradient background.

Organisation:

University of Edinburgh

Peter is Biofoundry Computational Biology Lead at the Edinburgh Genome Foundry, University of Edinburgh.

Sign up to our termly newsletter for news, events and opportunities from our centre. We won’t spam or share your information.

Regenerating injured hearts and reversing established damage with genetic medicines.

Quick links

Governance
Newsletter

Connect with us

Email our team
Find us on LinkedIn

© MRC/BHF CoRE in Advanced Cardiac Therapies 2026

Footer

Accessibility
Cookies
Privacy
Terms of use